Product Name

  • Name

    Azaperone

  • EINECS 216-715-8
  • CAS No. 1649-18-9
  • Article Data6
  • CAS DataBase
  • Density 1.168 g/cm3
  • Solubility very slightly Soluble in water
  • Melting Point 87-89 °C
  • Formula C19H22FN3O
  • Boiling Point 499.46 °C at 760 mmHg
  • Molecular Weight 327.402
  • Flash Point 255.864 °C
  • Transport Information UN2811 6.1/PG 3
  • Appearance Off-white solid
  • Safety 3/14
  • Risk Codes 22
  • Molecular Structure Molecular Structure of 1649-18-9 (Azaperone)
  • Hazard Symbols HarmfulXn
  • Synonyms Butyrophenone,4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]- (6CI,8CI);4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone;Fluoperidol;NSC 170976;R-1929;Stresnil;Suicalm;
  • PSA 36.44000
  • LogP 3.00870

Azaperone Specification

The Azaperone, with the CAS registry number 1649-18-9, is also known as 4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone. It belongs to the product categories of Active Pharmaceutical Ingredients; Aromatics; Heterocycles; Intermediates & Fine Chemicals; Pharmaceuticals. Its EINECS number is 216-715-8. This chemical's molecular formula is C19H22FN3O and molecular weight is 327.40. What's more, its systematic name is 1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone. Its classification codes are: (1)Antipsychotic; (2)Antipsychotic Agents; (3)Central Nervous System Agents; (4)Central Nervous System Depressants; (5)Dopamine Agents; (6)Dopamine antagonists; (7)Drug / Therapeutic Agent; (8)Hypnotics and Sedatives; (9)Neurotransmitter Agents; (10)Psychotropic Drugs; (11)Tranquilizing Agents. This chemical is harmful if swallowed. It is a pyridinylpiperazine and butyrophenone neuroleptic drug with sedative and antiemetic effects, which is used mainly as a tranquilizer in veterinary medicine. It is used mainly in pigs and elephants.

Physical properties of Azaperone are: (1)ACD/LogP: 3.044; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.19; (4)ACD/LogD (pH 7.4): 2.15; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 15.46; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 137.59; (9)#H bond acceptors: 4; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 6; (12)Polar Surface Area: 36.44 Å2; (13)Index of Refraction: 1.568; (14)Molar Refractivity: 91.668 cm3; (15)Molar Volume: 280.197 cm3; (16)Polarizability: 36.34×10-24cm3; (17)Surface Tension: 45.9 dyne/cm; (18)Density: 1.168 g/cm3; (19)Flash Point: 255.864 °C; (20)Enthalpy of Vaporization: 76.786 kJ/mol; (21)Boiling Point: 499.46 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: Fc1ccc(cc1)C(=O)CCCN3CCN(c2ncccc2)CC3
(2)Std. InChI: InChI=1S/C19H22FN3O/c20-17-8-6-16(7-9-17)18(24)4-3-11-22-12-14-23(15-13-22)19-5-1-2-10-21-19/h1-2,5-10H,3-4,11-15H2
(3)Std. InChIKey: XTKDAFGWCDAMPY-UHFFFAOYSA-N

The toxicity data is as follows: 

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo oral > 20mg/kg (20mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 1798, 1974.
dog LDLo subcutaneous > 40mg/kg (40mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 1798, 1974.
guinea pig LD50 oral 202mg/kg (202mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 1798, 1974.
mouse LD50 intraperitoneal 63mg/kg (63mg/kg) BEHAVIORAL: REGIDITY

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
Farmaco, Edizione Scientifica. Vol. 35, Pg. 605, 1980.
mouse LD50 intravenous 42mg/kg (42mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: TREMOR
Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 1798, 1974.
mouse LD50 oral 385mg/kg (385mg/kg) BEHAVIORAL: TREMOR

SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 1798, 1974.
mouse LD50 subcutaneous 179mg/kg (179mg/kg)   "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 185, 1972.
rat LD50 intravenous 25mg/kg (25mg/kg)   "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 185, 1972.
rat LD50 oral 245mg/kg (245mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 1798, 1974.
rat LD50 subcutaneous 450mg/kg (450mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: TREMOR
Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 1798, 1974.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View